BioCentury
ARTICLE | Company News

Asterand, Rubicon deal

July 3, 2006 7:00 AM UTC

The companies partnered to develop cancer diagnostics. The deal combines tissue and biofluid samples from Asterand with Rubicon's MethylPlex technology for discovering methylated DNA markers. Asterand...